Registration No.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________
Amendment No. 1 to
FORM S-3/A
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
_______________________
DNA PLANT TECHNOLOGY CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 22-395856
(State or other jurisdiction of (I.R.S. Employer Identification
incorporation or organization) No.)
6701 San Pablo Avenue
Oakland, California 94608-1239
(510) 547-2395
(Address, including zip code, and telephone number,
including area code of registrant's principal executive offices)
Robert Serenbetz
6701 San Pablo Avenue
Oakland, California 94608-1239
(510) 547-2395
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
___________________________________
Copies to:
Henry O. Smith III, Esq.
Proskauer Rose Goetz & Mendelsohn LLP
1585 Broadway
New York, New York 10036
(212) 969-3000
__________________________________
Approximate date of commencement of proposed sale to public: As soon
as practicable after the Registration Statement becomes effective.
If the only securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
of 1933, other than securities offered only in connection with dividend or
interest reinvestment plans, check the following box [X]
The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant
shall file a further amendment which specifically states that this
Registration Statement shall thereafter become effective in accordance with
Section 8(a) of the Securities Act of 1933 or until the Registration Statement
shall become effective on such date as the Commission, acting pursuant to said
Section 8(a), may determine.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this
Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Oakland, State of California, on
June 22, 1995.
DNA PLANT TECHNOLOGY CORPORATION
By: /S/ ROBERT SERENBETZ
Robert Serenbetz
Chairman of the Board and
Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in the
capacities and on the dates indicated.
<TABLE>
<CAPTION>
Signatures Title Date
<S> <C> <C>
/S/ ROBERT SERENBETZ Chairman of the June 22, 1995
Robert Serenbetz Board and Chief
Executive Officer
(Principal
Executive Officer)
/S/ CHRIS BRAUNLICH Chief Financial June 22, 1995
Chris Braunlich Officer and
Treasurer
(Principal
Financial Officer
and Principal
Accounting Officer
/S/ * Director June 22, 1995
Evenlyn Berezin
/S/ * Director June 22, 1995
James L. Ferguson
/S/ * Director June 22, 1995
Gerald D. Laubach
/S/ * Director June 22, 1995
Douglas S. Luke
*By /S/ CHRIS BRAUNLICH June 22, 1995
Chris Braunlich, as
Attorney-in-fact
</TABLE>
